ReviewPharmaceuticals (Basel, Switzerland)2023

Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis.

Hannah J Van de Roovaart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.